//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
ProfilePosts









Loading...
I am thrilled to share our latest paper, "AAV8 based gene replacement therapy for hereditary spastic paraplegia type 5," just published in Molecular Therapy - Methods & Clinical Development! @dzne.science @hih-tuebingen.bsky.social @tueneurocampus.bsky.social
'Stem Cells in Neuroscience' is returning to Tübingen, Germany. SAVE THE DATE: February 25-27, 2026. More info: stemcelltuebingen.com Please share #stemcelltuebingen2026 @dzne.science @hih-tuebingen.bsky.social @unituebingen.bsky.social @tueneurocampus.bsky.social
Don't forget, the abstract deadline for SCMND 2025 is next month! Check out scmnd.com for more information! #ipsc #stemcells #neuroscience #Edinburgh #neurodegeneration #organoids
Let's meet in Edinburgh! Registration & abstract deadline are fast approaching. Register now: ➡️ scmnd.com ⬅️
Join us for 𝗦𝘁𝗲𝗺 𝗖𝗲𝗹𝗹𝘀 𝗶𝗻 𝗡𝗲𝘂𝗿𝗼𝘀𝗰𝗶𝗲𝗻𝗰𝗲, 𝟮𝟱𝘁𝗵-𝟮𝟳𝘁𝗵 𝗼𝗳 𝗙𝗲𝗯𝗿𝘂𝗮𝗿𝘆, 𝟮𝟬𝟮𝟲 in Tübingen, Germany. Register here until 30th of November: 👉 www.stemcelltuebingen.com 👈 Please repost and spread the news! @dzne.science @hih-tuebingen.bsky.social @tueneurocampus.bsky.social @unituebingen.bsky.social
Here's our incredible FULL LINEUP of speakers for #SCMND2025! Abstract submission closes Friday! scmnd.com @rikvanderkant.bsky.social @selinawray.bsky.social @carlescalatayud.bsky.social @rcasterton.bsky.social @annawilliamslab.bsky.social @sergiuppasca.bsky.social @neuralstemcells.bsky.social
📢 Möchten Sie die Zukunft des HIH mitgestalten? Wir suchen zum nächstmöglichen Zeitpunkt eine neue Geschäftsführung (m/w/d), Stellenumfang 75%-100%. 📝 Bewerbungen bitte bis zum 08.10.25 👉 Link zur Stellenausschreibung tinyurl.com/3cmvhz9d
Join us for 𝗦𝘁𝗲𝗺 𝗖𝗲𝗹𝗹𝘀 𝗶𝗻 𝗡𝗲𝘂𝗿𝗼𝘀𝗰𝗶𝗲𝗻𝗰𝗲, 𝟮𝟱𝘁𝗵-𝟮𝟳𝘁𝗵 𝗼𝗳 𝗙𝗲𝗯𝗿𝘂𝗮𝗿𝘆, 𝟮𝟬𝟮𝟲 in Tübingen, Germany. Register here until 30th of November: 👉 stemcelltuebingen.com Speaker slots and stipends available Please repost and spread the news! @dzne.science @hih-tuebingen.bsky.social @tueneurocampus.bsky.social
Warm wishes for a wonderful holiday season and a New Year that’s full of creativity, inspiration, and achievement.
Help shape the future of neurodegeneration research – in a leading role at DZNE and the University Tübingen! The DZNE and the Faculty of Medicine invite applications for the position of a Full Professor (W3) for Neurodegenerative Diseases to be filled immediately. 👉 www.nature.com/naturecareer...
11mo
Dec 18, 2024
Jan 21, 2025
7mo
11mo
Jan 27, 2025
8mo
9mo
Dec 20, 2024
Dec 17, 2024
The German Center for Neurodegenerative Diseases (DZNE) is a world-leading internationally oriented research center in the Helmholtz Association, c...
www.nature.com
Full Professor (W3) in Neurodegenerative Diseases - Tübingen, Baden-Württemberg (DE) job with University of Tübingen - Faculty of Medicine | 12834224
Stefan Hauser
Stefan Hauser
Stefan Hauser
Stefan Hauser
Stefan Hauser
Bowles Lab
Bowles Lab
Hertie-Institut für klinische Hirnforschung (HIH)
DZNE research center
DZNE research center
#MTMCD
Neurons, astrocytes, microglia, oligodendrocytes, blood brain barrier, organoids, chips... we've got it all covered! 🧠 Check out our full list of speakers (and register to come see them) at scmnd.com! #iPSC #neuroscience #neurodegeneration #organoid #stemcells
11mo
Jan 16, 2025
dlvr.it
AAV8-mediated gene therapy targeting the liver effectively normalized peripheral oxysterol levels in a mouse model of hereditary spastic paraplegia type 5 (SPG5). However, brain oxysterol levels remained partially corrected, indicating that successful SPG5 treatment requires a gene therapy approach that also targets the central nervous system.
AAV8 based gene replacement therapy for hereditary spastic paraplegia type 5
Bowles Lab
Molecular Therapy Family of Journals